Meiji Seika Kaisha, Ltd.

Masaharu Shiotani

Kiyoaki Katano

Tetsuya Matsushima

Naoto Ohkura

Tetsutaro Niizato

Yukiko Hiraiwa

Shigeki Suzuki

Yuuko Nakatani

Takashi Tsuruoka

Takayuki Usui

Kazue Sasaki

Takehiro Yamamoto

Mieko Nagasawa

Chizuko Kuroda

Chidsuko Kuroda

Yoko Shoji

Disclosed are compounds represented by formula (I) which have triglyceride biosynthesis inhibitory activity in the liver and inhibitory activity against the secretion of apolipoprotein B-containing lipoprotein from the liver and particularly have excellent inhibitory activity against the secretion of apolipoprotein B-containing lipoprotein, are free from side effect of accumulation of lipids in the liver, and are useful for the treatment and prevention of hyperlipidemia and arteriosclerotic diseases. In formula (I), Rand Rrepresent alkyl, alkoxy, cycloalkyl, phenyl, alkenyl, alkynyl, or a five- or six-membered saturated or unsaturated heterocyclic ring, or Rand R, together with a nitrogen atom to which Rand Rare attached, may form a ring; Rand Rrepresent a hydrogen atom, alkyl, a halogen atom, hydroxyl, nitrile, alkoxycarbonyl, alkoxy, or carboxyl; or Rand Rmay be attached to each other to form &#x2014;(CH)&#x2014;, &#x2014;N&#x2550;CH&#x2014;, &#x2014;CH&#x2550;N&#x2014;, or &#x2014;(Calkyl)C&#x2550;N&#x2014;; A, D, E, and G each represent a carbon atom, or any one of A, D, E, and G represents a nitrogen atom with the other three each representing a carbon atom; Q represents a nitrogen atom or a carbon atom; Y represents a group represented by formula (II) wherein X represents a hydrogen atom, group &#x2014;C(&#x2550;O)N(R)Ror group &#x2014;C(&#x2550;O)OR, Ris absent or represents a bond, an oxygen atom, a sulfur atom, &#x2014;SO&#x2014;, &#x2014;SO&#x2014;, &#x2014;CH&#x2014;CH&#x2014;, or &#x2014;CH&#x2550;CH&#x2014;, and Rand Rrepresent a hydrogen atom, alkyl, alkoxy, a halogen atom, or hydroxyl; and Z represents &#x2014;(CH)&#x2014;, &#x2014;O&#x2014;(CH)&#x2014;, or &#x2014;C(&#x2550;O)NH&#x2014;(CH)&#x2014;

Nitrogen-containing heterocyclic compounds and benzamide compounds and drugs containing the same

Disclosed are compounds represented by formula (I) which have triglyceride biosynthesis inhibitory activity in the liver and inhibitory activity against the secretion of apolipoprotein B-containing lipoprotein from the liver and particularly have excellent inhibitory activity against the secretion of apolipoprotein B-containing lipoprotein, are free from side effect of accumulation of lipids in the liver, and are useful for the treatment and prevention of hyperlipidemia and arteriosclerotic diseases. In formula (I), R and R represent alkyl, alkoxy, cycloalkyl, phenyl, alkenyl, alkynyl, or a five- or six-membered saturated or unsaturated heterocyclic ring, or R and R , together with a nitrogen atom to which R and R are attached, may form a ring; R and R represent a hydrogen atom, alkyl, a halogen atom, hydroxyl, nitrile, alkoxycarbonyl, alkoxy, or carboxyl; or R and R may be attached to each other to form &mdash;(CH ) &mdash;, &mdash;N&boxH;CH&mdash;, &mdash;CH&boxH;N&mdash;, or &mdash;(C alkyl)C&boxH;N&mdash;; A, D, E, and G each represent a carbon atom, or any one of A, D, E, and G represents a nitrogen atom with the other three each representing a carbon atom; Q represents a nitrogen atom or a carbon atom; Y represents a group represented by formula (II) wherein X represents a hydrogen atom, group &mdash;C(&boxH;O)N(R )R or group &mdash;C(&boxH;O)OR , R is absent or represents a bond, an oxygen atom, a sulfur atom, &mdash;SO &mdash;, &mdash;SO&mdash;, &mdash;CH &mdash;CH &mdash;, or &mdash;CH&boxH;CH&mdash;, and R and R represent a hydrogen atom, alkyl, alkoxy, a halogen atom, or hydroxyl; and Z represents &mdash;(CH ) &mdash;, &mdash;O&mdash;(CH ) &mdash;, or &mdash;C(&boxH;O)NH&mdash;(CH ) &mdash;.

Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same

Nitrogen-containing heterocyclic compounds and therapeutic agents for hyperlipidemia comprising the same

Fosfomycin or a pharmaceutically acceptable salt thereof has been found to have an action of lowering the serum glucose level and is recognized to be useful as an orally administrable remedy for treating diabetes. It has further been found that the serum glucose level-lowering action of fosfomycin or its salt can be enhanced synergistically and significantly when forfomycin is administered in association with vanadyl sulfate and the like. Therefore,the composition comprising fosfomycin or its salt and vanadyl sulfate or the like is useful as an orally administrable remedy for treating diabetes.

Method for treatment of diabetes

Nitrogenous heterocyclic compounds and hyperlipemia remedy containing the same

Fosfomycin or a pharmaceutically acceptable salt thereof has been found to have an action of lowering the serum glucose level and is recognized to be useful as an orally administrable remedy for treating diabetes. It has further been found that the serum glucose level-lowering action of fosfomycin or its salt can be enhanced synergistically and significantly when fosfomycin is administered in association with vanadyl sulfate and the like. Therefore, the composition comprising fosfomycin or its salt and vanadyl sulfate or the like is useful as an orally administrable remedy for treating diabetes.

Composition for treatment of diabetes and treatment of diabetes

Growing community of inventors

Yokohama, Japan

Masaharu Shiotani